Table 1 Diagnostic capabilities, appropriate location and procedures for microbiological and routine tests in 48 referral center for HID in 16 European countries
Diagnostic capabilities | Evaluation score* | ||
|---|---|---|---|
A Fully/mostly | B Partially | C Not | |
Achieved | achieved | Achieved | |
N (%) | N (%) | N (%) | |
Topic 1: The isolation facility has access to BSL-4 labs or capabilities/protocols for the safe and appropriate handling of group 4 agent specimens for diagnosis | 11/48 (23) | 30/48 (62) | 7/48 (15) |
Topic 2: The isolation facility has access to BSL-3 labs or capabilities/protocols for the safe and appropriate handling of group 3 agent specimens for diagnosis | 39/48 (81) | 9/48 (19) | 0/48 |
Topic 3: The isolation facility has capabilities/procedures for the safe and appropriate management of other tests/routine analysis in HID patients (i.e., use of bed-side tests inside isolation area or use of central hospital lab after inactivation of samples or without inactivation but with appropriate measures of biosecurity and biosafety, including the use of automatic, closed-type system analyzers) | 16/48 (33) | 19/48 (40) | 13/48 (27) |
Appropriate location and procedures for microbiological or routine tests | microbiological test | routine test | Â |
N (%) | N (%) | ||
Inside the isolation area (same room or other room) | 8/47 (17) | 13/48 (27) | Â |
In the BSL-3 reference lab | 32/47 (68) | 15/48 (31) | Â |
In the general lab, with closed-type automatized analyzers | 19/47 (40) | 26/48 (54) | Â |
In the general lab, without closed-type automatized analyzers | 5/47 (11) | 15/48 (31) | Â |